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We report the first case of avian influenza in a patient
with fever and diarrhea but no respiratory symptoms. Avian
influenza should be included in the differential diagnosis for
patients with predominantly gastrointestinal symptoms,
particularly if they have a history of exposure to poultry.
I
nfluenza A viruses are classified into subtypes (hemag-
glutinin and neuraminidase subtypes) based on antigenic
differences in their surface glycoproteins (1). Of 15 identi-
fied hemagglutinin (H1–H15) and 9 neuraminidase sub-
types (N1–N9), only 3 hemagglutinin subtypes (H1, H2,
and H3) and 2 neuraminidase subtypes (N1 and N2) have
established stable lineages in humans (1). Because the nat-
ural reservoir of known influenza A subtypes is found in
birds and waterfowl (2), subtypes other than those typical-
ly found in humans have the potential to cross the species
barrier and infect humans (3).
Avian influenza A virus H9N2 was isolated from two
children in Hong Kong in 1999, and avian influenza H7N7
infected 89 persons during a simultaneous outbreak in poul-
try in the Netherlands in 2003 (4–7), although these infec-
tions resulted in only mild illnesses. The first outbreak of a
highly pathogenic avian influenza (H5N1) in humans
occurred in Hong Kong in 1997; 6 of 18 people with con-
firmed infection died (5,8). Despite attempts to prevent dis-
ease, two cases of influenza A H5N1 occurred in Hong
Kong in February 2003 (1), followed by outbreaks in
Vietnam and Thailand in January 2004 (9,10). Data are lim-
ited on the epidemiologic characteristics, signs and symp-
toms, and outcomes of avian influenza H5N1 exposure in
healthcare workers. We report atypical avian influenza
H5N1 and follow-up surveillance of 35 exposed healthcare
workers; we also review relevant literature in this area.
The Case
On March 9, 2004, a 39-year-old woman with no
underlying disease was transferred to our hospital with
rapidly progressive pneumonia. At the referring hospital,
she reported fever for 1 week, diarrhea, nausea, and vom-
iting, with no early respiratory symptoms. Initial laborato-
ry values at the referring hospital included the following:
leukocyte count 3,300 cells/mm3, total lymphocyte count
640 cells/mm3, hemoglobin 13 g/dL, and platelet count
400,000 cells/mm3. Stool samples and cultures were nega-
tive for bacteria and parasites. Because the patient had no
respiratory symptoms, no chest radiograph was performed
on initial admission. Norfloxacin was prescribed. On hos-
pital day 5, cough and shortness of breath developed, and
chest radiograph was performed (Figure 1A). Norfloxacin
was changed to ceftazidime and amikacin, and the patient
was transferred. 
Upon arrival at our hospital, her temperature was
39.4°C, respiratory rate 44/min, blood pressure 110/80 mm
Hg, and heart rate 140 beats/minute. She was intubated,
and the examination showed bilateral crackles. Laboratory
data included leukocyte count 2,200 cells/mm3 with total
lymphocyte counts of 440 cells/mm3, hemoglobin 11.1
g/dL, platelet count 330,000 cells/mm3, aspartate amino-
transferase 474 U/L, alanine aminotransferase 106 U/L,
alkaline phosphatase 546 U/L, blood urea nitrogen 11
mg/dL, creatinine 1.6 mg/dL, partial thromboplastin time
35.4 s, prothrombin time 11.9 s, and lactase dehydrogenase
1,832 mg/dL. Imipenem, azithromycin, and doxycycline
were administered as adult respiratory distress syndrome
progressively developed. Infectious disease consultation
was requested the next day, and additional exposure histo-
ry was obtained from the family. 
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Figure 1. A. Chest radiograph on hospital day 5 at referring hospi-
tal shows patchy infiltration at bilateral lower lung fields. B. Chest
radiograph upon admission to our hospital (24 hours later) shows
rapidly progressive pneumonia in both lung fields, compatible with
adult respiratory distress syndrome.The patient and five family members live together in a
rural area of Ayudhaya in central Thailand. Her family
reported that she was exposed to several dead chickens in
her neighborhood. Neighborhood chickens were noted
frequently to roam around the patient’s house, and some
had died in front of it. All her family members were well,
with no symptoms of influenzalike illness. After the expo-
sure history was obtained, droplet and contact precautions
were implemented, and the patient was evaluated for
H5N1 influenza. Nasopharnygeal aspirates underwent a
rapid influenza A test by enzyme immunomembrane filter
assay (Directigen Flu A, Becton Dickinson, Sparks, MD)
was negative, and additional tests for viral particles were
performed by reverse transcriptase–polymerase chain
reaction (RT-PCR), real-time RT-PCR, and viral culture.
Because of the negative rapid influenza Atest and the lack
of access to antiviral medication, neuraminidase inhibitors
were not prescribed, but intravenous prednisone was initi-
ated. The patient died from severe adult respiratory dis-
tress syndrome (Figure 1B) with multiorgan failure the
next day. 
Nasopharnygeal aspirates were positive for influenza A
H5 strain by two RT-PCR primers (Figure 2) and by real-
time RT-PCR. Three sets of blood cultures, sputum cul-
tures, and serologic tests were negative for the following:
Chlamydia by microimmunofluorescence, mycoplasma by
microparticle agglutination assay, urine Legionella antigen
by enzyme-linked immunosorbent assay (ELISA), HIV by
ELISA,  Burkholderia pseudomallei (melioid) titer by
immunohistochemical assay, dengue titer by hemaggluti-
nation inhibition using all four serotypes, Leptospira titer
by microscopic agglutination test, Widal test, Weil-Felix
test, and viral culture. Several dead chickens around the
neighborhood near the patient’s house tested positive for
H5N1 by viral cultures. The patient’s family declined to
permit an autopsy.
Thirty healthcare workers at our hospital and five
healthcare workers at the referring hospital were exposed
to this index patient without using appropriate personal
protective equipment. All of them were monitored for 2
weeks for temporally related influenzalike illness, and
temperatures were measured twice weekly. No temporally
related influenzalike illness or fever developed. The char-
acteristics and types of exposure reported by influenza A
H5N1–exposed healthcare workers are summarized in the
Table.
Viral culture for avian influenza H5N1 was conducted
on Madin-Darby canine kidney cell monolayers at the
Department of Medical Sciences, National Institute of
Health, Bangkok. Nasopharyngeal aspiration specimens
tested positive by an RT-PCR assay specific for the hemag-
glutinin gene of influenza AH5N1. The specimen was test-
ed with the primer set for the H5 gene (forward primer
H5-1 GCC ATT CCA CAA CAT ACA CCC, reverse
primer H5-2 TAA ATT CTC TAT CCT CCT TTC CAA),
with an expected product size of 358 bp (8). The specimen
was confirmed positive by different RT-PCR primers (for-
ward primer H5-1456 ACG TAT GAC TAT CCA CAA
TAC TCA, reverse primer H5-1685 AGA CCA GCTACC
ATG ATT GC), which amplify a DNAfragment of 229 bp.
This specimen was further confirmed as positive by using
the real-time RT-PCR method, including primer and probe,
described by Spackman et al. (11). This assay amplifies a
conserved region of European and Asian avian influenza
virus and was modified to run on the LightCycler (Roche
Molecular Systems, Indianapolis, IN). Precautions for pre-
venting cross-contamination were observed (12). 
Conclusions
The clinical signs and symptoms of avian influenza
H5N1 may be more protean than originally described.
During the 1997 epidemic in Hong Kong, patients exhibit-
ed fever, headache, malaise, myalgia, sore throat, cough,
and rhinitis (5,8). Although uncommon, conjunctivitis and
gastrointestinal symptoms were also reported (5,8). In the
2004 epidemic in Vietnam, prominent clinical signs and
symptoms of avian influenza H5N1 were those of a severe
influenza syndrome with fever, cough, diarrhea, and short-
ness of breath. Of note, diarrhea was present in 7 (70%) of
10 patients along with lower respiratory symptoms (9).
The preliminary clinical features of avian influenza H5N1
in the 2004 epidemic in Thailand included fever, cough,
sore throat, rhinorrhea, myalgia, and shortness of breath
(10). Laboratory findings of patients with severe avian
DISPATCHES
1322 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 7, July 2004
Figure 2. A) Reverse transcription–polymerase chain reaction (RT-
PCR) specific for H5 gene band (358 bp) of avian influenza H5N1
that was recovered from our patient from nasopharyngeal aspi-
rates by using H5-1/H5-2 primer. Lane A, molecular standard; lane
B, H5 band isolated from our patient (358 bp); lane C, negative
control; lane D, positive control. B) RT-PCR specific for H5 gene
band (229 bp) of avian influenza (H5N1) that was recovered from
our patient from nasopharyngeal aspiration by using H5-1456/H5-
1685 primer. Lane A, molecular standard; lane B, positive control;
lane C, H5 band isolated from our patient (229 bp). influenza H5N1 are undistinguishable from those of
patients with prevailing human influenza; findings include
leukopenia, lymphopenia, impaired liver function, pro-
longed clotting times, and renal impairment (5,8–10). To
our knowledge, this patient has the first reported case of
H5N1 with fever and gastrointestinal symptoms but no res-
piratory symptoms.
As of this submission, 22 patients in Vietnam and 12 in
Thailand have confirmed cases of avian influenza H5N1.
Twenty-three (67%) of 34 infected patients have died. The
death rate of H5N1 was 33% (6 of 18 patients) in Hong
Kong in 1997, 73% (15 of 22 patients) in Vietnam in 2004,
and 67% (8 of 12 patients) in Thailand in 2004. Risk fac-
tors associated with severe disease and poor outcome of
H5N1 included older age, being symptomatic for a longer
period before admission, pneumonia, leukopenia, and lym-
phopenia (8). Patients <5 years of age had mild disease
compared with hospitalized adults (8). However, all cases
of H5N1 from Thailand occurred in pediatric patients,
except for our patient and one previously reported patient
(10). No H5N1 patients in Thailand had underlying or con-
comitant disease (10).
Avian influenza (H5N1) can be isolated by convention-
al viral culture methods (1). Several reports suggested that
rapid influenza tests, H5-specific RT-PCR, and real-time
RT-PCR could aid a rapid diagnosis (1,2,11,13,14).
However, rapid diagnostic tests for influenza have low
sensitivity, which may limit their usefulness to reliably
detect H5N1, especially if illnesses are diagnosed later in
their clinical course (1), as in our patient. Thus, clinical
findings and a history of poultry exposure may be more
helpful in identifying patients with H5N1 infection than
the result on rapid diagnostic tests for influenza.
Data are limited on human-to-human transmission of
avian influenza H5N1. Whether H5N1 could be efficiently
transmitted from human to human is a matter of concern.
In a matched case-control study of 15 patients with H5N1,
exposure to live poultry in the week before symptom onset
was significantly associated with H5N1 disease, while
traveling, eating or preparing poultry products, and recent
exposure to persons with respiratory illness had no signif-
icant association (15). A cohort study conducted among
persons infected with H5N1 to detect anti-H5 antibody
among their household and social contacts suggests that
human-to-human transmission might have occurred
through close physical contact with H5N1-infected
patients, whereas social exposure to an infected person
was not associated with H5N1 infection (16). 
Another cohort study, which included healthcare work-
ers from three hospitals where H5N1 patients had been
admitted, found a significantly higher rate of seropositivi-
ty for H5N1 among exposed workers (8 [3.7%] of 217 per-
sons) than among nonexposed workers (2 [0.7%] of 309
persons), which provides evidence of H5N1 transmission
from infected patients to healthcare workers (17). In our
study, although 33 (94%) of 35 healthcare workers were
exposed to the index patient within 1 m, they did not
exhibit fever or influenzalike illness during our 2-week
follow-up period (Table). However, we cannot rule out
mild or subclinical infection because of the lack of data on
anti-H5 serology. Together, these studies confirm that
healthcare workers are at low risk of acquiring H5N1 from
patients, but continued precautions and monitoring are
essential in case the virus evolves to become more trans-
missible among humans. In conclusion, physicians work-
ing in areas where H5N1 is endemic should be aware of
unusual cases. A high index of suspicion will facilitate
prompt diagnosis and proper management. 
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administered breathing treatment 
Changed bed linens 
Bathed patient 
Temporally related illness
a 
28 (23–34) 
27 (77) 
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19 (54) 
3 (8) 
33 (94) 
2 (6) 
20 (57) 
 
7 (20) 
10 (35) 
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